Contents

Inflammation & Allergy - Drug Targets (Discontinued), Volume 12 - Number 2

Editorial

Editorial (Hot Topic :Advances in Industry for Chronic Respiratory Diseases)

, 12(2): 79 - 80

Lynne A. Murray and Darryl A. Knight


DOI: 10.2174/1871528111312020001




Inhalation Delivery of Protein Therapeutics

, 12(2): 81 - 87

Colleen Kane, Karyn O’Neil, Michelle Conk and Kristen Picha


DOI: 10.2174/1871528111312020002




Reflections on MicroRNAs in Chronic Pulmonary Disease: Looking into the miR-ror and Crystal Ball

, 12(2): 88 - 98

James G. Karras, Guizhen Sun, Jia Tay and Aimee L. Jackson


DOI: 10.2174/1871528111312020003




Engineering Approaches to Develop the Next Generation of Antibodies to Respiratory Targets

, 12(2): 99 - 108

Katherine A. Vousden, Deborah L. Clarke and David C. Lowe


DOI: 10.2174/1871528111312020004




Recombinant Protein Based Therapeutics for IPF

, 12(2): 109 - 123

Joseph M. Parker, Michael S. Kramer and Lynne A. Murray


DOI: 10.2174/1871528111312020005




Predicting Drug Efficacy Using Integrative Models for Chronic Respiratory Diseases

, 12(2): 124 - 131

Christopher S. Stevenson, Sriram Sridhar and Jonathan E. Phillips


DOI: 10.2174/1871528111312020006




Intravenous Immunoglobulın Therapy in Dermatology: An Update

, 12(2): 132 - 146

Seray Kulcu Cakmak, At l Cakmak, Muzeyyen Gonul, Arzu K l c and Ulker Gul


DOI: 10.2174/1871528111312020007




Basophil Activation Test with Indomethacin to Assess Hypersensitivity to Non-Steroidal Anti-Inflammatory Drugs: A Preliminary Study

, 12(2): 147 - 151

Zamir Calamita, Roseli Nunes da Silveira Antunes, Andrea Bronhara Pela Calamita, Wilson Baleotti Junior, Debora de Aguiar Cavaretto, Josianne Thomazini Fukazawa and Odilon Marques de Almeida Filho


DOI: 10.2174/1871528111312020008




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science